SUBSTANCE-P-INDUCED INFLAMMATORY RESPONSES IN GUINEA-PIG SKIN - THE EFFECT OF SPECIFIC NK1 RECEPTOR ANTAGONISTS AND THE ROLE OF ENDOGENOUS MEDIATORS

被引:75
作者
WALSH, DT [1 ]
WEG, VB [1 ]
WILLIAMS, TJ [1 ]
NOURSHARGH, S [1 ]
机构
[1] NATL HEART & LUNG INST,DEPT APPL PHARMACOL,LONDON SW3 6LY,ENGLAND
基金
英国惠康基金;
关键词
SUBSTANCE P; EOSINOPHILS; NEUTROPHILS; EDEMA FORMATION; INFLAMMATION; CP-96,345; RP-67,580; CHLORPHENIRAMINE; UK-74,505; ZM-230,487;
D O I
10.1111/j.1476-5381.1995.tb13354.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The sensory neuropeptide substance P (SP), when released from sensory nerves, has been implicated in the development of neurogenic inflammation. In the present study, using an in vivo model system, we have characterized and investigated the mechanisms underlying SP-induced leukocyte accumulation and oedema formation in the guinea-pig. 2 Intradermally injected SP (i.d., 10(-13)-10(-9) mol per site), induced a dose- and time-dependent accumulation of In-111-neutrophils, In-111-eosinophils and oedema formation as measured by the local accumulation of i.v. injected I-125-albumin. The leukocyte accumulation evoked by SP was significant at 10(-10) and 10(-9) mol per site, whereas oedema formation was significant at the lowest dose tested (10(-13) mol per site). 3 The NK1 receptor antagonists, CP-96,345 (1 mg kg(-1), i.v.) and RP-67,580 (10 mu g per site, i.d.), significantly attenuated the oedema formation induced by the lower doses of SP. Oedema formation and leukocyte accumulation induced by 10(-9) mol per site SP were unaffected by either antagonist. 4 SP-elicited responses were not significantly affected by the platelet activating factor (PAF) receptor antagonist, UK-74,505 (2.5 mg kg(-1), i.v.) or the H-1 histamine receptor antagonist, chlorpheniramine (10(-8) mol per site, i.d.), However, the In-111-eosinophil accumulation, but not the In-111-neutrophil accumulation or oedema formation, induced by SP was significantly inhibited by the specific 5-lipoxygenase (5-LO) inhibitor, ZM-230,487 (10(-8) mol per site, i.d.). 5 The accumulation of both In-111-neutrophils and In-111-eosinophils induced by SP was abolished in guinea-pigs treated i.v. with an anti-CD18 monoclonal antibody 6.5E F(ab')(2) (2.5 mg kg(-1)). The oedema response was unaffected in these animals. 6 These results suggest that SP-induced inflammatory events may be mediated via two mechanisms involving NK1 receptor-dependent and independent pathways. Oedema formation induced by the lower doses of SP may be mediated via the direct activation of NK1 receptors whilst, at higher doses, oedema formation and leukocyte accumulation may be mediated via the release of secondary mediators, possibly mast cell derived, with 5-LO products playing an important role in the leukocyte infiltration. The leukocyte accumulation, but not the oedema induced by SP, is dependent on the expression of the CD18 antigen on leukocytes.
引用
收藏
页码:1343 / 1350
页数:8
相关论文
共 47 条
[1]  
ALABASTER VA, 1991, NEW DRUGS ASTHMA THE, P221
[2]   KIM185, A MONOCLONAL-ANTIBODY TO CD18 WHICH INDUCES A CHANGE IN THE CONFORMATION OF CD18 AND PROMOTES BOTH LFA-1-DEPENDENT AND CR3-DEPENDENT ADHESION [J].
ANDREW, D ;
SHOCK, A ;
BALL, E ;
ORTLEPP, S ;
BELL, J ;
ROBINSON, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2217-2222
[3]  
ANSEL JC, 1993, J IMMUNOL, V150, P4478
[4]   RELATIONSHIPS BETWEEN PERMEABLE VESSELS, NERVES, AND MAST-CELLS IN RAT CUTANEOUS NEUROGENIC INFLAMMATION [J].
BARANIUK, JN ;
KOWALSKI, ML ;
KALINER, MA .
JOURNAL OF APPLIED PHYSIOLOGY, 1990, 68 (06) :2305-2311
[5]   SUBSTANCE-P REGULATES THE VASODILATOR ACTIVITY OF CALCITONIN GENE-RELATED PEPTIDE [J].
BRAIN, SD ;
WILLIAMS, TJ .
NATURE, 1988, 335 (6185) :73-75
[6]   4-METHOXY-2-METHYLTETRAHYDROPYRANS - CHIRAL LEUKOTRIENE BIOSYNTHESIS INHIBITORS, RELATED TO ICI D2138, WHICH DISPLAY ENANTIOSELECTIVITY [J].
CRAWLEY, GC ;
BRIGGS, MT ;
DOWELL, RI ;
EDWARDS, PN ;
HAMILTON, PM ;
KINGSTON, JF ;
OLDHAM, K ;
WATERSON, D ;
WHALLEY, DP .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (02) :295-296
[7]  
DEROSE V, 1994, J IMMUNOL, V152, P1339
[8]  
EBISAWA M, 1992, J IMMUNOL, V149, P4021
[9]  
FACCIOLI LH, 1991, IMMUNOLOGY, V73, P222
[10]   HISTAMINE-RELEASE AND VASCULAR CHANGES INDUCED BY NEUROPEPTIDES [J].
FOREMAN, J ;
JORDAN, C .
AGENTS AND ACTIONS, 1983, 13 (2-3) :105-116